Working... Menu

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 in Adults With Advanced Solid Tumors and Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02392611
Recruitment Status : Completed
First Posted : March 19, 2015
Last Update Posted : October 20, 2017
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 11, 2017
  Actual Study Completion Date : October 11, 2017